What is the Impact Factor of Antiviral Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Antiviral Research is 4.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Antiviral Research indexed in Web of Science or Scopus?

Yes, Antiviral Research is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.353 (Q1) and an H-index of 162.

Who publishes Antiviral Research and what is the Article Processing Charge (APC)?

Antiviral Research is published by Elsevier. The estimated Article Processing Charge (APC) is approximately $3,627 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Antiviral Research?

The official ISO-4 abbreviation of Antiviral Research is "ANTIVIR RES" with common acronym "avr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #2,937Hybrid

Antiviral Research

Acronym:avr

•

Abbreviation (ISO):ANTIVIR RES

•

Identifier (ISSN):0166-3542(Print)/1872-9096(Online)

•

Publisher:Elsevier

Official Website Submission Portal Compare

Clarivate IF (2026)

4.3↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Antiviral Research

WoS Q2

Annual Impact Factor Metric

Current (2026):4.3

Scopus SJR & RankScopus Q1

1.353

#2,937

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

162

162 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate4.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

139articles/year

38.98% Gold OA•100% Original Research

Aims & Scope

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action; new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.

Topics Covered (Recognized by AI)

Medicine89.6%Biology88.9%Virology82.5%Genetics78.9%Immunology74.6%Chemistry71.7%Biochemistry66.2%Virus64.9%Gene41.6%Internal medicine36.9%Family medicine28%Human immunodeficiency virus (HIV)27.8%Organic chemistry24.3%Cell culture23%Pathology22.2%In vitro21.6%Physics21.5%Pharmacology20.5%

Primary Research Areas

Medicine Virology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile 1 Calls for Papers

1 calls

Special Issues

Calls for Papers

1 Calls for Papers · Automatically synced from ScienceDirect & publishers

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank95/356

IndexSCIE

JCRSCIE2026

VIROLOGY

Rank7/44

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank53/356

IndexSCIE

JCISCIE2026

VIROLOGY

Rank5/44

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	95/356	Q2
VIROLOGY	JCRSCIE	7/44	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	53/356	Q1
VIROLOGY	JCISCIE	5/44	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.3

Articles / Year136

Total Citations52

2025

IF4

Articles / Year183

Total Citations603

2024

IF4.5

Articles / Year209

Total Citations1,584

2023

IF7.6

Articles / Year184

Total Citations2,282

2022

IF10.103

Articles / Year197

Total Citations3,887

Year	Impact Factor	Articles / Year	Total Citations
2026	4.3	136	52
2025	4	183	603
2024	4.5	209	1,584
2023	7.6	184	2,282
2022	10.103	197	3,887
2021	5.97	146	3,021
2020	4.101	224	15,199
2019	4.13	224	7,419
2018	4.307	234	9,846
2017	—	272	11,748
2016	—	258	11,070
2015	—	206	10,054

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,937Scopus Q1SCImago Profile

Scopus Coverage:1959, 1981-2026

•

Scopus Broad Areas:Immunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.353

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.29

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,627 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,355

3-Year Documents545

Citable Documents543

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate44.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1

VirologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Antiviral Research (acronym: avr, abbr: ANTIVIR RES, ISSN: 0166-3542) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 1981. The periodical holds a Journal Impact Factor (JIF) of 4.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.353 (Q1), an H-index of 162.

The journal enforces rigorous peer evaluation with an average review speed of 9.6周, a publication frequency of Monthly, an annual output of approximately 139 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,627 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.